Literature DB >> 7654947

Integrating the ECG power-line interference removal methods with rule-based system.

N Kumaravel1, A Senthil, K S Sridhar, N Nithiyanandam.   

Abstract

The power-line frequency interference in electrocardiographic signals is eliminated to enhance the signal characteristics for diagnosis. The power-line frequency normally varies +/- 1.5 Hz from its standard value of 50 Hz. In the present work, the performances of the linear FIR filter, Wave digital filter (WDF) and adaptive filter for the power-line frequency variations from 48.5 to 51.5 Hz in steps of 0.5 Hz are studied. The advantage of the LMS adaptive filter in the removal of power-line frequency interference even if the frequency of interference varies by +/- 1.5 Hz from its normal value of 50 Hz over other fixed frequency filters is very well justified. A novel method of integrating rule-based system approach with linear FIR filter and also with Wave digital filter are proposed. The performances of Rule-based FIR filter and Rule-based Wave digital filter are compared with the LMS adaptive filter.

Mesh:

Year:  1995        PMID: 7654947

Source DB:  PubMed          Journal:  Biomed Sci Instrum        ISSN: 0067-8856


  3 in total

1.  Removal of power-line interference from the ECG: a review of the subtraction procedure.

Authors:  Chavdar Levkov; Georgy Mihov; Ratcho Ivanov; Ivan Daskalov; Ivaylo Christov; Ivan Dotsinsky
Journal:  Biomed Eng Online       Date:  2005-08-23       Impact factor: 2.819

2.  A hybrid approach to the simultaneous eliminating of power-line interference and associated ringing artifacts in electrocardiograms.

Authors:  Xiaolin Zhou; Yuanting Zhang
Journal:  Biomed Eng Online       Date:  2013-05-14       Impact factor: 2.819

Review 3.  Fetal ECG extraction from abdominal signals: a review on suppression of fundamental power line interference component and its harmonics.

Authors:  Dragoş-Daniel Ţarălungă; Georgeta-Mihaela Ungureanu; Ilinca Gussi; Rodica Strungaru; Werner Wolf
Journal:  Comput Math Methods Med       Date:  2014-02-09       Impact factor: 2.238

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.